Advaxis, Inc. - Financial and Strategic Analysis Review

Advaxis, Inc. - Financial and Strategic Analysis Review

Advaxis, Inc., (Advaxis) is a development stage Biotechnology Company, engaged in the research and development of new cancer-fighting techniques. It develops cancer vaccines for the treatment of cervical, breast, prostate, ovarian, lung, and other cancers. Its products in development include Lovaxin C, Lovaxin P, Lovaxin B and Lovaxin SCCE. It is headquartered at North Brunswick in New Jersey, United States.

Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Advaxis, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.

Scope

• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors' weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

This report covers the following industry codes:

SIC Code: 2836

NAICS Code: 325414

• Key Information
• Key Ratios
• Share Data
• Performance Chart
• Key Facts
• Business Description
• Major Products and Services
• Overview
• History
• SWOT Analysis Overview
• Overview
• Advaxis, Inc. - Strengths
• Competitive Advantage of Lovaxin C
• Exclusive Rights over Technology
• Advaxis, Inc. - Weaknesses
• Loss from Operational Activities
• Dependence on Third Party Manufacturer
• Advaxis, Inc. - Opportunities
• Potential Market for Cancer Products
• Collaborations and Agreements
• Rising Healthcare Expenditure in the US
• Advaxis, Inc. - Threats
• Dependence on the License Agreement with Penn
• Highly Competitive Market
• Tightening of FDA's Regulatory Oversight
• Key Competitors
• Key Employees
• Key Employee Biographies
• \Locations And Subsidiarie
• Head Office
• Financial Ratios
• Capital Market Ratios
• Annual Ratios
• Interim Ratios
• Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Advaxis, Inc., Key Facts
  • Advaxis, Inc., Key Ratios
  • Advaxis, Inc., Share Data
  • Advaxis, Inc., Key Facts
  • Major Products and Services
  • Advaxis, Inc., History
  • Advaxis, Inc., Key Employees
  • Advaxis, Inc., Key Employee Biographies
  • Advaxis, Inc., Ratios based on current share price
  • Advaxis, Inc., Annual Ratios
  • Advaxis, Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Advaxis, Inc., Performance Chart (2004 - 2008)
  • Advaxis, Inc., Ratio Charts